David Reddy

David Reddy is the Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) since April 2024, representing the innovative pharmaceutical industry and fostering global health progress. David serves on the Board of Directors and various committees for the Coalition for Epidemic Preparedness (CEPI) since January 2018, working to finance and coordinate vaccine development. In addition, David is the interim Chair of the Board of Trustees for MALARIA NO MORE UK TRADING LIMITED and previously was the CEO of Medicines for Malaria Venture (MMV) until April 2024. David's experience also includes key leadership roles at the RBM Partnership to End Malaria and Hoffmann-La Roche, focusing on pandemic preparedness and global business management in HIV. David holds a PhD in Cellular and Molecular Biology, an MSc (Hons) in Cell Biology, and a BSc in Cellular and Molecular Biology from the University of Auckland.